138 related articles for article (PubMed ID: 8738960)
21. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats.
Xiao BG; Bai XF; Zhang GX; Link H
J Neuroimmunol; 1998 Apr; 84(2):230-7. PubMed ID: 9628468
[TBL] [Abstract][Full Text] [Related]
22. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
23. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
26. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
[TBL] [Abstract][Full Text] [Related]
27. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats.
Huang YM; Yang JS; Xu LY; Link H; Xiao BG
Clin Exp Immunol; 2000 Dec; 122(3):437-44. PubMed ID: 11122252
[TBL] [Abstract][Full Text] [Related]
28. 2-Buten-4-olide (2-B4O) inhibits experimental allergic encephalomyelitis (EAE) in Lewis rats.
Naiki M; Takeoka Y; Yago H; Kurimoto Y; Gershwin ME; Suehiro S
J Autoimmun; 1995 Oct; 8(5):727-39. PubMed ID: 8579727
[TBL] [Abstract][Full Text] [Related]
29. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats.
Huitinga I; Ruuls SR; Jung S; Van Rooijen N; Hartung HP; Dijkstra CD
Clin Exp Immunol; 1995 May; 100(2):344-51. PubMed ID: 7743675
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance.
Pender MP; McCombe PA; Yoong G; Nguyen KB
J Autoimmun; 1992 Aug; 5(4):401-10. PubMed ID: 1384526
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
32. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
[TBL] [Abstract][Full Text] [Related]
33. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
[TBL] [Abstract][Full Text] [Related]
35. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
Pope L; Paterson PY; Miller SD
J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
[TBL] [Abstract][Full Text] [Related]
36. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats.
Mustafa MI; Diener P; Höjeberg B; Van der Meide P; Olsson T
J Neuroimmunol; 1991 Feb; 31(2):165-77. PubMed ID: 1704016
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
[TBL] [Abstract][Full Text] [Related]
38. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
[TBL] [Abstract][Full Text] [Related]
39. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.
Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H
J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroid treatment of experimental autoimmune encephalomyelitis in the Lewis rat results in loss of V beta 8.2+ and myelin basic protein-reactive cells from the spinal cord, with increased total T-cell apoptosis but reduced apoptosis of V beta 8.2+ cells.
McCombe PA; Nickson I; Tabi Z; Pender MP
J Neuroimmunol; 1996 Nov; 70(2):93-101. PubMed ID: 8898717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
